Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kathryn C Zoon Insider Profile
4 Followers
Kathryn C Zoon, Director at Emergent Biosolutions, holds 54.48K shares in Emergent Biosolutions (Ticker: EBS). Most recently, Kathryn C Zoon Sold $10,000 shares of Emergent Biosolutions on Jun 06, 2024 for an estimated value of 61.10K.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
0.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Kathryn C Zoon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 08, 2018 - Nov 08, 2019
Return:+20.00%
The most profitable trade made by Kathryn C Zoon
Kathryn C Zoon's Trading History
List of latest transactions for each holding click on a transaction to see Kathryn C Zoon's performance on stock
You May Also Like
Kathryn C Zoon insider profile FAQ
What is the percentage of profitable transactions made by Kathryn C Zoon?
The percentage of profitable transactions made by Kathryn C Zoon is 67%.
What is the average return per transaction made by Kathryn C Zoon?
The average return per transaction made by Kathryn C Zoon is 0.00%.
What stocks does Kathryn C Zoon hold?
Kathryn C Zoon holds: EBS stocks.
What was Kathryn C Zoon’s latest transaction?
Kathryn C Zoon latest transaction was an Informative Sell of $61.10K.
What was Kathryn C Zoon's most profitable transaction?
Kathryn C Zoon’s most profitable transaction was an Informative Sell of EBS stock on November 8, 2018. The return on the trade was 20.00%.
What is Kathryn C Zoon's role in Emergent Biosolutions?
Kathryn C Zoon's role in Emergent Biosolutions is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.